J. Goldman & CO LP Pfizer Inc Call Options Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $11.2 Million - $13.1 Million	350,000 New	350,000 $11.6 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $5.63 Million - $7.16 Million	-168,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $5.34 Million - $6.27 Million	168,300 New	168,300 $6.18 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.